AdvaMed® Comments to HHS Deregulation RFI

The State Medtech Alliance (SMTA) connects state and regional medtech associations across the U.S. to share best practices, coordinate advocacy, and improve patient access to medical technology.

AdvaMed opposes renewal of the medical device repair exemption, citing new legal and manufacturer evidence that the prior rulemaking record no longer supports renewal.

When is software not just software? That’s the question at the center of comments AdvaMed recently filed with the U.S. Copyright Office. At first glance, this may sound like a narrow dispute about medical device repair. In reality, it reflects a broader challenge facing a software-driven economy: how should the law treat software that is distinct from, but connected to, the products it supports?

Behind every policy conversation is a patient waiting for access to the care and technology they need. In this edition of AdvaMed in Action, Bobby Patrick explores how collaboration among patient advocates, medtech companies, state partners and policy leaders can help advance patient access and turn shared priorities into meaningful action.

AdvaMed urges OIG to modernize Anti-Kickback Statute and Beneficiary Inducements CMP rules with a clinical trial-specific safe harbor to provide greater clarity for reasonable participant remuneration and support arrangements.

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner. 

AdvaMed Code of Ethics Certification Directory

WASHINGTON, D.C. – AdvaMed today announced that Juan Carlos “JC” Scott has been appointed Chief Strategy Officer and Executive Director of AdvaMed Accel, a newly created leadership position focused on accelerating engagement with emerging medical technology companies and strengthening AdvaMed’s role at the center of the innovation ecosystem.